Product
Chosen Chemotherapy
1 clinical trial
1 indication
Indication
Breast Cancer MetastaticClinical trial
A Randomized, Open-Label, Multiple-center, Phase II Study to Evaluate the Efficacy and Safety of Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of Chinese Patients With HER2+ Metastatic Breast Cancer Who Have Received Prior Anti-HER2 TherapiesStatus: Active (not recruiting), Estimated PCD: 2021-09-03